Rallis India has informed that the Board of Directors of the Company on February 27, 2024, based on the recommendation of the Nomination & Remuneration Committee, have approved the appointment of Narain Duraiswami (DIN: 03310642) as an Additional Director (Independent, Non-Executive) effective March 1, 2024. Further, the Board has approved his appointment as an Independent Director for a term of 5 years with effect from March 1, 2024 up to February 28, 2029, subject to approval of the shareholders. The disclosures as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, concerning the above appointment is enclosed as Annexure I to this intimation. These are also being made available on the website of the Company at www.rallis.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| UPL | 665.00 |
| PI Industries | 3144.45 |
| Bayer CropScience | 4900.45 |
| Sharda Cropchem | 1109.70 |
| Sumitomo Chemical | 441.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: